Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 1, 2023. (Total: 223516Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Asthenia and KRAS[original query]
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.
The lancet oncology 2012 Nov .
Jänne PA, Shaw AT, Pereira JR, Jeannin G, Vansteenkiste J, Barrios C, Franke FA, Grinsted L, Zazulina V, Smith P, Smith I, Crinò L
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Aug 24 (8): 2062-7.
Fornaro L, Lonardi S, Masi G, Loupakis F, Bergamo F, Salvatore L, Cremolini C, Schirripa M, Vivaldi C, Aprile G, Zaniboni A, Bracarda S, Fontanini G, Sensi E, Lupi C, Morvillo M, Zagonel V, Falcone
Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study.
Cancer 2013 Aug 119 (15): 2754-64.
Karampeazis Athanasios, Voutsina Alexandra, Souglakos John, Kentepozidis Nikos, Giassas Stelios, Christofillakis Charalambos, Kotsakis Athanasios, Papakotoulas Pavlos, Rapti Ageliki, Agelidou Maria, Agelaki Sofia, Vamvakas Lambros, Samonis George, Mavroudis Dimitris, Georgoulias Vassil
Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.
British journal of cancer 2016 Feb 114 (4): 372-80.
Elez E, Hendlisz A, Delaunoit T, Sastre J, Cervantes A, Varea R, Chao G, Wallin J, Tabernero
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
British journal of cancer 2019 Jul .
Elez Elena, Pericay Carles, Valladares-Ayerbes Manuel, Bando Inmaculada, Safont Maria Jose, Gallego Javier, Grávalos Cristina, Arrivi Antonio, Carrato Alfredo, Conde Verónica, Ortiz Maria José, López Carlos, Alonso Beatriz, Ruiz de Mena Inmaculada, Díaz-Rubio Eduardo, Tabernero Josep, Aranda Enriq
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data.
Scientific reports 2021 7 11 (1): 14321.
Fernández Montes Ana, Carmona-Bayonas Alberto, Jimenez-Fonseca Paula, Vázquez Rivera Francisca, Martinez Lago Nieves, Covela Rúa Marta, Cousillas Castiñeiras Antía, Gonzalez Villarroel Paula, De la Cámara Gómez Juan, Méndez José Carlos Méndez, Carriles Fernández Carmen, Sanchez Cánovas Manuel, Garcia García Tere
TOP